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Charcot-Marie-Tooth disease (CMT) with autosomal recessive (AR) inheritance is a heterogeneous group of in-
herited motor and sensory neuropathies. In some families from Japan and Brazil, a demyelinating CMT, mainly
characterized by the presence of myelin outfoldings on nerve biopsies, cosegregated as an autosomal recessive trait
with early-onset glaucoma. We identified two such large consanguineous families from Tunisia and Morocco with
ages at onset ranging from 2 to 15 years. We mapped this syndrome to chromosome 11p15, in a 4.6-cM region
overlapping the locus for an isolated demyelinating ARCMT (CMT4B2). In these two families, we identified two
different nonsense mutations in the myotubularin-related 13 gene, MTMR13. The MTMR protein family includes
proteins with a phosphoinositide phosphatase activity, as well as proteins in which key catalytic residues are missing
and that are thus called “pseudophosphatases.” MTM1, the first identified member of this family, and MTMR2
are responsible for X-linked myotubular myopathy and Charcot-Marie-Tooth disease type 4B1, an isolated pe-
ripheral neuropathy with myelin outfoldings, respectively. Both encode active phosphatases. It is striking to note
that mutations in MTMR13 also cause peripheral neuropathy with myelin outfoldings, although it belongs to a
pseudophosphatase subgroup, since its closest homologue is MTMR5/Sbf1. This is the first human disease caused
by mutation in a pseudophosphatase, emphasizing the important function of these putatively inactive enzymes.
MTMR13 may be important for the development of both the peripheral nerves and the trabeculum meshwork,
which permits the outflow of the aqueous humor. Both of these tissues have the same embryonic origin.
Introduction
Charcot-Marie-Tooth disease (CMT) is a heterogeneous
group of inherited motor and sensory neuropathies char-
acterized by chronic distal weakness with progressive
muscular atrophy and sensory loss in the distal extrem-
ities (Dyck 1975). CMT is one of the most common
hereditary disorders, affecting ∼1/2,500. Electrophys-
iological measures—in particular, median motor nerve
conduction velocities (median MNCV)—distinguish ax-
onal (MNCV 140 m/s) from demyelinating (MNCV !35
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m/s) forms (Harding and Thomas 1980; Bouche et al.
1983). The mode of inheritance can be autosomal dom-
inant, X-linked, or autosomal recessive (ARCMT). For
the demyelinating forms of ARCMT, eight different loci
have been reported, on chromosomes 5q (CMT4C
[MIM 601596]) (LeGuern et al. 1996), 8q13-q21.1
(CMT4A [MIM 214400]) (Ben Othmane et al. 1993),
8q24 (HMSNL [MIM 601455]) (Kalaydjieva et al.
1996), 10q (ERG2 [MIM 129010]) (Warner et al. 1998),
11q23 (CMT4B1 [MIM 601382]) (Bolino et al. 1996),
11p15 (CMT4B2 [MIM 604563]) (Ben Othmane et al.
1999), and 19q (CMT4F [MIM 145900]) (Delague et
al. 2000). Five genes have been identified, EGR2 (MIM
129010) (Warner et al. 1998), MTMR2 (MIM 603557;
the CMT4B1 locus) (Bolino et al. 2000),NDRG1 (MIM
605262) (Kalaydjieva et al. 2000), PRX (MIM 605725)
(Boerkoel et al. 2001; Guilbot et al. 2001), and GDAP1
(MIM 606598) (Baxter et al. 2002; Cuesta et al. 2002),
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corresponding to the 10q, CMT4B1, HMSNL, CMT4F,
and CMT4A loci, respectively.
Glaucoma is characterized by progressive loss of vi-
sual fields and degeneration of the optic nerve, usually
associated with increased intraocular pressure (IOP).
Glaucoma in the first 40 years of life includes congenital/
infantile glaucoma, which manifests before age 5 years;
juvenile primary open-angle glaucoma (JOAG [MIM
137750]), in which the age at onset ranges from 5 to
40 years; and variants that are associated with abnor-
malities of the anterior chamber of the eye. These dis-
eases are genetically heterogeneous. Seven loci have
been reported for autosomal dominant forms, but only
two genes have been identified: MYOC/TIGR (MIM
601652) (Stone et al. 1997), the GLC1A locus (MIM
601682) on chromosome 1q25; and OPTN (MIM
602432) on chromosome 10p14 (Rezaie et al. 2002).
For autosomal recessive glaucoma, three genes have
been identified: CYP1B1 (MIM 601771) (Stoilov et al.
1997), the GLC3A locus (MIM 231300) on chromo-
some 2p21; PITX2 (MIM 601542) (Semina et al. 1996),
the IRID2 locus (MIM 137600) on 4q25; and FOXC1
(MIM 601090) (Nishimura et al. 1998), the IRID1 lo-
cus (MIM 601631) on 6p25.
Two groups (Arruda et al. 1999; Kiwaki et al. 2000)
have reported the association between a demyelinating
CMT, mainly characterized by myelin outfoldings on
nerve biopsies, and early-onset glaucoma (EOG), seg-
regating as an autosomal recessive trait. In two large
consanguineous families with this phenotype from Tu-
nisia and Morocco, we have mapped this syndrome to
11p15, in a region overlapping the locus for an isolat-
ed demyelinating ARCMT with myelin outfoldings
(CMT4B2) (Ben Othmane et al. 1999), and we have
identified two nonsense mutations in the causative
gene, MTMR13, a member of the phosphatase-inactive
subgroup within the myotubularin-related gene family.
Patients and Methods
Patients
The index patients in families TUN-RE and RBT-HAD
and 23 at-risk relatives (fig. 1) were examined for the
presence of motor and sensory loss, areflexia, foot de-
formities, scoliosis, and other associated signs, such as
nerve hypertrophy, tremor, ataxia, pyramidal signs, cra-
nial nerve involvement, and dementia. They also un-
derwent an ophthalmologic examination. The electro-
physiological examination was performed in all patients
and at-risk relatives. Seven patients were clinically af-
fected. All other family members examined, including
both parents, were found to be normal on clinical and
electrophysiological examination.
Genotyping
Blood samples from the 25 members from the Tunisian
and Moroccan families were obtained after informed con-
sent was given. Genomic DNA was extracted using stan-
dard procedures. Family members were genotyped with
microsatellite markers, to test linkage to known demye-
linating CMT and primary open-angle glaucoma (POAG)
loci. The CMT loci are 17p11.2 (CMT1A [MIM
118220]) (Timmerman et al. 1990), 1q22-23 (CMT1B
[MIM 118200], the MPZ gene [MIM 159440]) (Haya-
saka et al. 1993), 10q23 (EGR2) (Warner et al. 1998),
5q23-q33 (CMT4C) (LeGuern et al. 1996), 8q13-q21 (the
CMT4A locus,GDAP1) (Ben Othmane et al. 1993), 8q24
(the HMSNL locus, NDRG1 [MIM 605262]) (Kalayd-
jieva et al. 1996), 11q23 (the CMT4B1 locus, MTMR2)
(Bolino et al. 1996); the POAG loci are 1q23-q25
(GLC1A) (Richards et al. 1994), 2cen-q13 (GLC1B
[MIM 606669]) (Stoilova et al. 1996), 3q21-q24
(GLC1C [MIM 606669]) (Wirtz et al. 1997), 6p25
(IRID1) (Jordan et al. 1997), 8q23 (GLC1D [MIM
602429]) (Trifan et al. 1998), 10p15-p14 (GLC1E [MIM
137760]) (Sarfarazi et al. 1998), 7q35-q36 (GLC1F
[MIM 603383]) (Wirtz et al. 1999), 2p21 (GLC3A [MIM
231300]) (Sarfarazi et al. 1995), and 1p36 (GLC3B
[MIM 600975]) (Akarsu et al. 1996). PCRs were per-
formed according to published procedures. The PCR
products were pooled, combined with the GeneScan HD
Rox 400 size standard, loaded onto a 4.8% PAGE-plus,
and run on the ABI PRISM 377 DNA Sequencer (Perkin-
Elmer/Applied Biosystems).
Linkage Analyses
Pairwise and multipoint LOD scores were calculated
using the MLINK and LINKMAP programs of the
FASTLINK package (Schaffer et al. 1994); a fully pen-
etrant autosomal recessive trait with a disease-allele fre-
quency of 0.0001 and an equal recombination fraction
(v) in males and females were assumed. We assigned
equal frequencies to the alleles observed in the families
studied. At-risk individuals who were clinically and elec-
trophysiologically normal at age 15 years were consid-
ered to be unaffected. Haplotypes were constructed ac-
cording to the principles of Thompson (1987). The order
of the markers was that of the consensus CEPH/Ge´ne´-
thon chromosome 11 linkage map in the Genome Da-
tabase (fig. 1).
Sequencing
All coding exons of the MTMR13 gene, including
exon-intron junctions, were amplified by PCR with
primers designed from the genomic sequences available
from GenBank (accession numbers XM_049218 and
XM_113650, replaced with XM_208513). Both strands
Figure 1 Haplotype reconstruction of 14 markers in the Tunisian (A) and Moroccan (B) families with demyelinating ARCMT and glaucoma.
Deduced haplotypes for individuals for whom DNA was not available are bracketed. Microsatellite markers are ordered, from telomere (top) to
centromere (bottom), according to the Ge´ne´thon genetic map. Boxes indicate the haplotype segregating with the disease, and shaded areas indicate
the common region of homozygosity. Recombination events are indicated by arrows.
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Table 1
Combined Two-Point LOD Scores for Chromosome 11p15 Markers in the TUN-RE and
RBT-HAD Families
MARKERa
LOD SCORE AT v p
Zmax
b vmax.0 .01 .05 .1 .2 .3 .4
D11S4046  4.39 2.75 1.64 .68 .29 .11 .11 .40
D11S1760 .27 3.40 3.66 3.41 2.56 1.59 .66 3.66 .05
D11S1331 5.67 5.54 5.05 4.43 3.18 1.96 .83 5.67 .00
D11S1338 1.42 1.38 1.22 1.01 .61 .27 .05 1.42 .00
D11S4188 5.61 5.48 4.98 4.34 3.05 1.81 .73 5.61 .00
D11S909 4.88 4.78 4.35 3.81 2.71 1.63 .66 4.88 .00
D11S932 6.19 6.06 5.54 4.88 3.55 2.23 .98 6.19 .00
D11S4149 6.25 6.12 5.60 4.94 3.59 2.24 .98 6.25 .00
D11S1329 3.31 3.24 2.95 2.59 1.86 1.14 .47 3.31 .00
D11S1999 5.06 4.95 4.51 3.96 2.83 1.73 .73 5.06 .00
D11S4194  2.44 3.35 3.32 2.66 1.76 .84 3.35 .00
D11S4189  1.43 2.40 2.47 2.00 1.31 .62 2.47 .00
D11S1334 3.09 3.03 2.77 2.45 1.81 1.18 .57 3.09 .00
a Markers are ordered according to the Marshfield linkage map (Center for Medical
Genetics Web site). Markers in boldface italic type are from the ABI PRISM linkage
mapping set version 2 (Applied Biosystems).
b The highest Zmax value is underlined.
of the PCR products were sequenced with BigDye Ter-
minators (Applied Biosystems) on an ABI 3100 se-
quencer. Sequence chromatograms were analyzed using
SeqScape software version 1.1 (Applied Biosystems). In
each family, the genotypes of at-risk members were de-
termined by direct sequencing of the exon containing
the mutation in the index patient.
RT-PCR
Total RNA was extracted from a human sciatic nerve,
through use of standard procedures. Total RNA from
the additional 10 human tissues used in the RT-PCR
experiments (shown in fig. 3) were purchased from Bec-
ton Dickinson (Clontech). First-strand cDNA was pre-
pared from 1 mg of RNA, through use of the Advantage
RT-for-PCR kit (Becton Dickinson; Clontech). RT-PCR
was performed using diluted cDNA, as recommended
by the manufacturer’s instructions, with 2 mM MgCl2
and 30 cycles of amplification.
Phylogenetic Analysis and Protein Domain Prediction
Protein sequences for members of the myotubularin
family from human, Drosophila melanogaster, and Sac-
charomyces cerevisiae were aligned using Clustal X
(Thompson et al. 1997), and the sequences encompass-
ing the PTPc/DSPc homology domain and the SET in-
teracting domain were realigned (corresponding to-
amino acids 1338–1520 in Hs MTMR13). The unrooted
tree was generated with Clustal X, through use of the
distance method based on amino acid identity. The pro-
tein sequences used in the tree and their NCBI or
SwissProt (Entrez-Protein) protein accession numbers
(in parentheses) are as follows: hMTM1 (Q13496),
hMTMR1 (Q13613), hMTMR2 (Q13614), hMTMR3
(Q13615), hMTMR4 (AAH35609), hMTMR5
(O95248), hMTMR6 (Q9Y217), hMTMR7 (Q9Y216),
hMTMR8 (AAH12399), hMTMR9 (CAC51114),
hMTMR10 (AK000320), hMTMR11 (AY028703),
ScMTM (P47147), DmCG3497 (AAF48390),
DmCG3530 (AAF46997), DmCG3632 (AAF48581),
DmCG6939 (AAK93570), DmCG3553 (AAF50343),
DmCG9115 (AAF52327). The sequences used can also
be found at the Institut de Ge´ne´tique et de Biologie Mo-
le´culaire et Cellulaire Web site. MTMR5 (Cui et al.
1998; Laporte et al. 1998), MTMR10, and MTMR11
(Nandurkar and Huysmans 2002) are also called “Sbf1”
(MIM 603560), “FLJ20313,” and “3-PAP,” respectively.
Protein domain prediction was performed with full-
length sequences by multiple sequence alignment and by
using the SMART (Letunic et al. 2002; SMART Web
site), Pfam (Bateman et al. 2002; Pfam Home Page), and
PSORT (Nakai and Kanehisa 1992; PSORT WWW
Server) databases.
Results
Mapping of the Gene Responsible for ARCMT
Associated with EOG
Two families were studied: one Tunisian family with
four affected members and one Moroccan family with
three affected members. Sensory motor neuropathy was
characterized by a mean age at onset of 8 years, a distal
motor deficit affecting the four limbs, MNCV !20 m/s,
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Figure 2 Physical map of 11p15 and genomic structure of MTMR13. A, Physical map of the critical region, including the position of the
linkage markers (top) and STS (bottom) tested. Physical distances (Ensembl Genome Browser; GenBank) are indicated in megabases. The marker
closest to the gene is in bold. B, Location of the two ESTs, LOC19611/LOC283105 and KIAA1766, from which the coding sequence of
MTMR13 (top) and intron-exon structure of MTMR13 (bottom) was constructed. This region was covered by four different genomic clones
from contig NT_028309.7. Clone AC080023.6 contains only the first exon of MTMR13. AC100763.2 includes exons 2 and 3 and partially
overlaps with clone AC011092.4, which extended from exons 3 to 17. The remaining portion of the gene is found in clone AC026250.16.
and alteration of sensory nerve action potentials. Myelin
outfoldings were observed at nerve biopsy in index pa-
tients. In the index patient of each family, visual im-
pairment was precocious and severe, leading to a loss
of vision. The ophthalmologic examination showed clear
signs of congenital glaucoma with a buphthalmos, a
megalocornea, and raised intraocular pressure. All the
other affected members of both families had increasing
intraocular pressure, which was in the upper normal
limits (16–20 mmHg). Results of clinical electrophys-
iological and ophthalmologic examinations of all par-
ents and examined at-risk subjects were normal (R.G.
and H.A., unpublished data).
All loci for demyelinating ARCMT and AR glaucoma
were excluded in both families, by means of haplotype
reconstruction and linkage analysis, except the locus in
11p15.3 reported by Ben Othmane et al. (1999). Positive
two-point LOD scores for both families reached a cu-
mulative maximum LOD score (Zmax) of 6.25 at ,vp 0
for D11S4149 (table 1). In family TUN-RE, the centro-
meric boundary of the candidate interval corresponded
to an inferred recombination between D11S1999 and
D11S4194, which was observed in individuals V10, V1,
and her mother IV2, and which conceivably occurred in
individual III15 (fig. 1). The telomeric boundary of the
region of homozygosity is delimited by the inferred re-
combination between D11S1760 and D11S1331, which
was observed in patient V1. These results place the disease
locus in a 4.6-cM interval between markers D11S1760
and D11S1329. Haplotype reconstruction in family RBT-
HAD, which defined a homozygosity region from marker
D11S1760 to D11S4189, did not help to refine the can-
didate region. The same alleles at markers D11S4149,
D11S1329, and D11S1999 were found in patients from
both families. Alleles were detected in patients from both
families for the eight microsatellites, as well as for the 18
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Figure 3 RT-PCR analysis of MTMR13 expression in several human tissues. A, RT-PCR performed using primers amplifying a fragment
corresponding to the first 1,250 bp of the MTMR13 ORF, starting from the ATG. A similar expression pattern was demonstrated for the
remaining four overlapping fragments into which the ORF was divided (not shown). B, G3PDH was used as positive control for the quality
of RNA and cDNA synthesis. MMLV is a control reaction in which the MMLV reverse transcriptase was omitted. RT corresponds to the
negative control of the PCR performed by omitting the cDNA thereafter.
additional markers within the candidate region excluding
a large genomic deletion (fig. 2A).
Identification of Mutations in MTMR13
At least 60 independent cDNA sequences were located
in the 4.6-cM candidate region. Two of them showed
homology to domains observed in members of the
MTMR family of protein phosphatases. Transcript
LOC196111 (GenBank accession number XM_113650),
which was replaced by LOC283105 (GenBank accession
number XM_208513), corresponded to an ORF of 1,482
bp, encoding a protein of 493 aa, sharing 53% identity
and 70% similarity, at the protein level, with MTMR5
(also called “Sbf1,” for SET binding factor 1 [NCBI pro-
tein accession number O95248]) (fig. 2B). The transcript
KIAA1766 (GenBank accession number XM_049218),
containing an ORF of 3,459 bp coding for a protein of
1,152 aa, had 59% similarity and 73% identity, at the
protein level, with a domain of MTMR5 closer to the N-
terminus than LOC196111. This suggested that both
mRNAs might belong to a transcript encoding the same
protein with high homology with MTMR5. To confirm
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Figure 4 Chromatograms of the mutation site sequence (arrow) are presented for both families. A, Family TUN-RE: a healthy homozygous
sib (V11), a heterozygous sib (V17), and an affected sib (V6); N:C/T (forward strand sequence). B, Family RBT-HAD: a heterozygous sib (IV5)
and two affected sibs (IV10 and IV14); N:A/G (reverse strand sequence).
this hypothesis, we performed BLAST searches with the
LOC196111 mRNA against EST databases (NCBI). An
EST sequence (Agencourt_6446961 [GenBank accession
number BM803570]) containing an ORF corresponding
to the last 100 bp of the KIAA1766 coding sequence, an
additional coding region of 198 bp, and the LOC196111
mRNA starting from its putative 5′ UTR were retrieved.
This allowed the reconstruction of a 5,550-bp ORF
encoding a 1,849-aa protein that we have named
“MTMR13.”
At the genomic level, 40 exons were identified, span-
ning a region of ∼600 kb (fig. 2). The MTMR13 coding
region has been confirmed by RT-PCR experiments per-
formed using total RNA from 20 different tissues. The
MTMR13 gene was found to be mainly expressed in
cerebellum, placenta, testis, fetal brain, and sciatic nerve
(fig. 3).
We initially tested one affected individual from each
family and a normal control individual for mutations in
MTMR13, by direct sequencing of all exons. We used
intronic primers (sequences available upon request) to
amplify the 40 coding exons and the exon-intron bound-
aries. In this way, two homozygous nonsense mutations,
2875CrT (Gln956Stop) in individual IV-10 from the
RBT-HAD pedigree and 3586CrT (Arg1196Stop) in in-
dividual V-4 from the TUN-RE pedigree, were identified
that were not present in the normal control (fig. 4). All
available family members were analyzed, and segrega-
tion of the mutations with the disease was confirmed in
both pedigrees. Both mutations, located in exons 23 and
27, respectively, were not detected by direct sequencing
in 50 control individuals of northern African ancestry
(100 chromosomes).
Hs MTMR13 Is a Putative Inactive Phosphatase
from the Myotubularin Family
MTMR13 is a newly discovered protein that shares
extensive homology with proteins from the myotubu-
larin family (Laporte et al. 2001; Wishart et al. 2001),
especially with MTMR5 (60% identity for the full-
length sequence). We aligned the most conserved region
of human, D. melanogaster, and S. cerevisiae myotu-
bularin proteins, including MTMR13, and performed a
phylogenetic analysis. The myotubularin family is di-
vided into six subgroups. MTMR13 belongs to a sub-
group that includes Hs MTMR5 and a D. melanogaster
protein, Dm CG6939 (fig. 5). MTMR13, like MTMR5,
has homology with the active site of tyrosine and dual-
specificity phosphatases (PTPc/DSPc). Their consensus
catalytic sequences, defined by CX5R in all active PTP/
DSP phosphatases, are degenerate. In particular, the con-
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Figure 5 Phylogenetic relationship of MTMR13 within the myotubularin family. The radial distance tree of the human, D. melanogaster,
and S. cerevisiae protein is shown, illustrating the six subgroups, each defined by one protein in D. melanogaster. MTMR13 belongs to the
same subgroup as MTMR5 (or Sbf1), its closest homologue (60% identity). MTMR2 belongs to the same subgroup as MTM1 and MTMR1
(70% identity with the latter). MTMR11 was also called “3-PAP” (Nandurkar and Huysmans 2002). While submitting this article, another
MTMR was published that is not included in this analysis (CRAa/b) (Wishart and Dixon 2002a). The scale represents the percentage of
divergence. Human genetic disorders associated with mutations in myotubularin protein are indicated: CMT4B1 (CMT type 4B1), CMT4B2
(CMT type 4B2 with early-onset glaucoma), and XLMTM (X-linked myotubular myopathy). The tree was generated using sequences encom-
passing the PTPc/DSPc homology domain and the SET interacting domain. Hs, Homo sapiens; Dm, D. melanogaster; Sc, S. cerevisiae.
served cysteine and arginine residues are absent (fig. 6).
MTMR13, like MTMR5, is thus a putative pseudo-
phosphatase with no predicted enzymatic activity. Hu-
man MTM1 and MTMR2, which belong to a different
subgroup of active phosphatases, are mutated in X-
linked myotubular myopathy (Laporte et al. 1996) and
in CMT type 4B1 (Bolino et al. 2000), respectively.
To gain insight into the putative function of
MTMR13, protein domains were predicted by the
SMART, PFAM, and PSORT databases and by com-
parison with known domains present in other myotu-
bularin proteins. Not surprisingly, MTMR13 had the
same organization as MTMR5 (fig. 6); in particular, the
DENN (Levivier et al. 2001) and GRAM (Doerks et al.
2000) domains, which are also found in regulators of
GTPase activity, although no specific functions have as
yet been assigned to them, and the SID (SET-interacting)
domain, which, in MTMR5, interacts with the SET do-
main of ALL-1, an epigenetic transcriptional regulator
(Cui et al. 1998).
Figure 6 Domain structure of MTMR13 and homologous proteins. Top, Scaled representations of Hs MTMR2, Hs MTMR5 (Sbf1), and
the three orthologous MTMR13 proteins in human (Hs MTMR13), D. melanogaster (Dm CG6939), and yeast (Sc MTM). The main protein
domains are depicted. The DENN (differentially expressed in neoplastic versus normal cells) domain is formed by three subdomains that are always
present together: uDENN, DENN, and dDENN (Levivier et al. 2001), all depicted as “DENN” here. In Dm CG6939, the first DENN subdomain
is missing, suggesting incomplete prediction of the N-terminus of the protein. The GRAM domain is found in glucosyltransferase, rab-like GTPase
activators and myotubularins and has no known function. The PTPc/DSPc homology domain (catalytic domain of tyrosine and dual-specificity
phosphatases) is found in all members. However, the consensus sequence of the catalytic pocket, present in Hs MTMR2 and Sc MTM, is degenerated
in Hs MTMR13. SET interacting domain (SID) was defined on the basis of interaction between Hs MTMR5 and proteins with SET (suvar 3–9,
enhancer-of-zeste, trithorax) domains and is present in all members. The PH domain (pleckstrin homology) is a phosphoinositide-binding domain.
Additional protein domains include a coiled-coil domain (amino acids 593–627) and a PDZ-binding domain (amino acids 640–643) at the C-
terminus of Hs MTMR2, a protein kinase C conserved region in Dm CG6939 (C1 domain/diacyglycerol and phrobol ester binding; amino acids
1546–1593), and the RID (Rac1-induced recruitment domain), the boundaries of which have not been defined (around amino acid 283 in Hs
MTMR2), and which is responsible for the plasma membrane recruitment of MTMR2 and other active and inactive homologues upon Rac 1
activation (Laporte et al. 2002). Bottom, Sequence alignment of the PTPc/DSPc homology domain in Hs MTMR13 and homologous proteins.
Names of the proteins are on the left, and the sequence intervals are on the right. Dm CG9115 is the D. melanogaster orthologue of Hs MTMR2
and Hs MTM1. Shaded amino acids are conserved in all the depicted proteins. The underlined sequence HCSDGWDRT is conserved 100% in all
active myotubularins from yeast to human and contains the compulsory consensus sequence CysX5Arg for the phosphatase activity. The catalytic
cysteine and arginine are indicated by stars.
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Discussion
We report the identification of the gene implicated for
a demyelinating ARCMT associated with early-onset
glaucoma. We first mapped the disease gene to chro-
mosome 11p15. Haplotype reconstruction in both fam-
ilies placed the candidate interval in a 4.6-cM region
flanked by markers D11S1760 and D11S4194. This lo-
cus overlaps the locus for CMT4B2 (Ben Othmane et
al. 1999), in which glaucoma was not reported (fig. 1).
Whether the same gene is responsible for the neuropathy
with or without glaucoma can not be affirmed. However,
the common North African origin (Tunisia and Mo-
rocco) of the families reported by both groups, their
common neuropathological features (myelin outfold-
ings), and the well known phenotypic inter- and intra-
familial variability associated with neuropathies are
compatible with the involvement of a same gene.
We first tested the hypothesis that a large deletion
disrupts two different genes affecting, independently,
the peripheral nervous system (PNS) and eye pheno-
types. Indeed, many disorders, such as Di George syn-
drome (MIM 188400), Smith-Magenis syndrome (MIM
182290), Williams-Beuren syndrome (MIM 194050),
and WAGR syndrome (MIM 194072), result from large
genomic deletions causing a contiguous gene syndrome.
However, a homozygous deletion was not detected in
the families in our study when the eight microsatellites
and 18 additional STS covering the candidate interval
were used (fig. 2A), excluding the hypothesis of a con-
tiguous gene syndrome.
We then analyzed the expressed sequences mapped in
the candidate region. A single cDNA sequence was re-
constructed from two apparently independent tran-
scripts. It corresponds to a new gene we have named
“MTMR13.” This gene, which is highly homologous to
MTMR5, belongs to the MTMR gene family. Nonsense
mutations in exons 23 and 27 were identified in the
index patients of families RBT-HAD and TUN-RE.
These stop mutations cosegregate with the disease in
the families. At the protein level, these mutations are
predicted to result in a truncated protein with deletion
of the PTPc/DSPc and SID homology domains. Trun-
cation of approximately half of the protein might also
result in instability. These results strongly support the
hypothesis that mutations in MTMR13 are responsible
for the phenotype.
To our knowledge, MTMR13 is the first pseudophos-
phatase mutated in a human disorder. Loss of function
of the pseudophosphatases STYX (Wishart and Dixon
2002b) and MTMR5 has recently been analyzed in the
mouse. Loss of MTMR5, the closest homologue of
MTMR13, causes a defect in late stages of spermato-
genesis (Firestein et al. 2002). Mutations of MTM1, a
close homologue of MTMR2, lead to myotubular my-
opathy (Laporte et al. 1996), a phenotype unrelated to
demyelinating CMT. Thus, while loss-of-function mu-
tations in MTMR2 (Bolino et al. 2000) and MTMR13
lead to related phenotypes, this is not the case for other
myotubularins. Furthermore, there is apparently no com-
plementation of MTMR13 loss of function by pseudo-
phosphatase homologues in the target tissues, suggesting
that MTMR13 has a specific function in the PNS and
eye or that the level or pattern of expression of myotu-
bularins differ. The fact that two forms of demyelinating
CMT4B are caused by loss-of-function mutations in ei-
ther an active phosphatase (MTMR2) and a pseudo-
phosphatase (MTMR13) contradicts the hypothesis that
pseudophosphatases act by competing with active phos-
phatases for their substrate (Cui et al. 1998). A common
function for MTMR2 and MTMR13 might lie in other
domains (DENN, GRAM, or SID, for example), and loss
of these domains would be responsible for the phenotype.
Another hypothesis is that the degenerate consensus
phosphatase domain acquires a new function in the same
transduction pathway as MTMR2. Myotubularin pseu-
dophosphatases have been proposed to act as adaptators
or modulators of phosphatases (Nandurkar et al. 2001).
Insight into the function of MTMR13 might be
gained from the known functions of its closest homo-
logue, MTMR5. The SET domain of ALL-1 was re-
cently shown to have histone methyltransferase activity
(Nakamura et al. 2002) that might be regulated through
interaction with the SID domains of MTMR5 and
MTMR13, affecting heterochromatin function. The PH
domain of MTMR5 binds PI(3,4)P2 and PI(3,4,5)P3 (Is-
akoff et al. 1998), and PI3P and PI3,5P2 are preferential
in vitro substrates for active myotubularins (Berger et
al. 2002). MTMR13 might thus be involved in phos-
phoinositide metabolism or regulation of SET proteins
and transcription.
The identification of a single gene involved in both a
demyelinating peripheral neuropathy and a early-onset
glaucoma is particularly interesting from a develop-
mental point of view. Indeed, mutations in MTMR13
might cause dysfunction of both Schwann cells, the my-
elinating cells in peripheral nerves, and cells of the tra-
beculum meshwork that permits outflow of the aqueous
humor. Both types of cells are derived from the neural
crest, as are different types of neurons and glial cells,
as well as melanocytes. Given the early onset of the
disease, we can hypothesize that MTMR13 is involved
in both the differentiation of Schwann cells during my-
elination and in the formation and development of the
trabeculum.
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